GLP-1 Menu Strategy Brief

Produce a brand-level strategic brief for adapting menu architecture, item-level macronutrient labeling, kiosk and digital-channel callouts, and AI-discoverability for the GLP-1 era — the structural shift toward smaller-portion, high-protein, lower-carb dining triggered by mass GLP-1 (Ozempic, Wegovy, Mounjaro, Zepbound) adoption. Covers the menu-section decision (build a dedicated GLP-1 / Protein-Forward section vs. embed callouts on existing items vs. both), macronutrient label design and FDA / FTC compliance, the kiosk and app badge system, the smaller-portion / half-size architecture, the cross-utilization map that keeps a new section affordable, the AI-feed adjustments that make the brand legible to Menu-Order-AI and in-assistant ordering apps, the test-market and rollout plan, the four-metric measurement plan, and the franchise-system communication pack. Produces a one-brand decision document — not a "GLP-1 is changing food" think piece.